Close

Alnylam Pharmaceuticals

Tracy Krughoff of BIO talks to Barry Greene, president and COO of Alnylam Pharmaceuticals (ALNY) at the Seventh Annual BIO Investor Forum in San Francisco. Alnylam has developed a deep pipeline of drug products to treat a multitude of diseases through RNAi therapeutics. Listen to the podcast